Combination of atorvastatin/coenzyme Q10 as adjunctive treatment in congestive heart failure: A double-blind randomized placebo-controlled clinical trial
Open Access
- 1 January 2014
- journal article
- Vol. 10 (1) , 1-5
Abstract
Heart failure is one of the leading causes of mortality, is a final common pathway of several cardiovascular diseases, and its treatment is a major concern in the science of cardiology. The aim of the present study was to compare the effect of addition of the coenzyme Q10 (CoQ10)/atorvastatin combination to standard congestive heart failure (CHF) treatment versus addition of atorvastatin alone on CHF outcomes. This study was a double-blind, randomized placebo-controlled trial. In the present study, 62 eligible patients were enrolled and randomized into 2 groups. In the intervention group patients received 10 mg atorvastatin daily plus 100 mg CoQ10 pearl supplement twice daily, and in the placebo group patients received 10 mg atorvastatin daily and the placebo of CoQ10 pearl for 4 months. For all patients echocardiography was performed and blood sample was obtained for determination of N-terminal B-type natriuretic peptide, total cholesterol, low density lipoprotein, erythrocyte sedimentation rate, and C-reactive protein levels. Echocardiography and laboratory test were repeated after 4 months. The New York Heart Association Function Class (NYHA FC) was also determined for each patient before and after the study period. Data analyses showed that ejection fraction (EF) and NYHA FC changes differ significantly between intervention and placebo group (P = 0.006 and P = 0.002, respectively). Changes in other parameters did not differ significantly between study groups. We deduce that combination of atorvastatin and CoQ10, as an adjunctive treatment of CHF, increase EF and improve NYHA FC in comparison with use of atorvastatin alone.Keywords
This publication has 21 references indexed in Scilit:
- Oxidative Stress and Heart Failure in Altered Thyroid StatesThe Scientific World Journal, 2012
- Effects of Carnitine and Coenzyme Q10 on Lipid Profile and Serum Levels of Lipoprotein(a) in Maintenance Hemodialysis Patients on Statin Therapy2011
- Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failureMedical Hypotheses, 2009
- Coenzyme Q10JACC, 2008
- Atorvastatin Improves Left Ventricular Systolic Function and Serum Markers of Inflammation in Nonischemic Heart FailureJACC, 2006
- Nitrosative stress and pharmacological modulation of heart failureTrends in Pharmacological Sciences, 2005
- Random allocation software for parallel group randomized trialsBMC Medical Research Methodology, 2004
- Coenzyme Q10 in patients with end‐stage heart failure awaiting cardiac transplantation: A randomized, placebo‐controlled studyClinical Cardiology, 2004
- Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease.2003
- Role of Coenzyme Q10 in Chronic Heart Failure, Angina, and HypertensionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001